WuXi's STA merges in drug development services
admin 31st July 2017 Uncategorised 0SynTheAll Pharmaceutical (STA), a subsidiary of China and U.S.-based WuXi AppTec that is focused on small-molecule drug manufacturing, is adding a drug development services operation as it builds itself into an end-to-end CDMO.
More: WuXi's STA merges in drug development services
Source: fierce